DowpharmaSM Announces Agreement with Pfizer

DowpharmaSM , a business unit of The Dow Chemical Company, has announced that it has entered into an agreement with Pfizer Inc to develop a cell line using Pfēnex Expression TechnologyTM, a Pseudomonas-based technology from Dowpharma.

Under the terms of the agreement, Pfizer will fund efforts at Dowpharma to evaluate the production of a Pfizer therapeutic protein using Pfēnex Expression TechnologyTM, as well as the use of a Dow proprietary solvent extraction technology. Additional financial details of the agreement were not disclosed.

“This agreement demonstrates the interest of the biopharmaceutical industry in producing therapeutic proteins using an expression system that delivers higher yields and process technologies that can reduce the overall cost of goods for biotherapeutics” said Nick Hyde, business director, Dowpharma. “In the cases that we have tested, PfÄ“nex consistently outperforms other commercially available microbial expression systems such as E. coli.”
  
Pfēnex Expression TechnologyTM is built around specially modified strains of Pseudomonas fluorescens bacteria that increase cellular expression while maintaining critical solubility and activity characteristics of recombinantly expressed therapeutic proteins.

“This agreement allows Pfizer, the world’s largest pharmaceutical company, to leverage the resources and technologies of the world's largest chemical company.  We believe our customized solutions and full spectrum of services will continue to meet and exceed the needs of our customers,” said Hyde.

More News:

  • IChemE Introduces New Academic Journal

    Sustainable Production and Consumption (SPC), a new academic journal from the Institution of Chemical Engineers (IChemE), in partnership with Elsevier, will launch in 2015 and focus on the importance of sustainability in sectors as diverse as retail, tourism, transport, health, food, energy, construction and the chemical and process industries.

  • Eastman Completes Taminco Acquisition

    Eastman Chemical Company completed its acquisition of specialty chemical producer Taminco Corporation.

  • Vertellus Acquires Dow SBH Business

    Vertellus, a producer of specialty chemicals for the life sciences sector and other industrial applications, signed a definitive agreement to acquire the sodium borohydride (SBH) business, including associated assets, from The Dow Chemical Company.

  • Energy Dept. Awards Pitt Grant To Improve Power Plant Safety

    The U.S. Department of Energy has tapped the University of Pittsburgh’s Swanson School of Engineering to help improve nuclear power plant safety.

  • NABE Forecasts Accelerated Economic Growth In Coming Year

    Economic growth is expected to accelerate in 2015, according to the December 2014 Outlook Survey from the National Association for Business Economics (NABE).

  • CHF Exhibit Features 15th Century Alchemical Manuscripts And Art

    Books of Secrets: Writing and Reading Alchemy, a new exhibit of alchemical art and documents, opened December 5 in the Museum at the Chemical Heritage Foundation (CHF).

  • AIChE Honors Stuart L. Cooper With Founders Award

    The American Institute of Chemical Engineers (AIChE) presented the Founders Award for Outstanding Contributions to the Field of Chemical Engineering, to Stuart L. Cooper, professor and chair of the Department of Chemical and Biomolecular Engineering at The Ohio State University.

  • Economic Reports Show Positive Week

    Economic reports were positive this week for the most part, according to Weekly Chemistry and Economic Trends report from the American Chemistry Council.

  • ACS Names New Executive Director

    Retiring DuPont executive will take helm

  • AkzoNobel Investigates Raw Material Production From Sugar Beet

    AkzoNobel joined forces with SuikerUnie, Rabobank, Deloitte, Investment and Development Agency for the Northern Netherlands (NOM), Groningen Seaports, and the Province of Groningen, to investigate the possibility of producing chemicals from beet-derived sugar feedstock

All news »

What are your comments?

Join the discussion today. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments